Antibody Therapeutics Patients First!

ĸ, ̳ؽ øøʡ Ź ü
  • ۾ PharmAbcine
  • ۼ 2020-06-18 11:25:35
  • ȸ 2202

ĸ̳ؽ øø  Ź  ü


[2020 6 18] ü ž ̿ ĸ(ǥ ) ̿Ǿǰ Ź߻(CDMO) ̳ؽ ڻ ַ ׾ü øø(Olinvacimab, TTAC-0001) ߰ ӻ ÷ Ź(Contract Manufacturing Organization, CMO) üߴٰ 18 .

 

̹ ĸ ̳ؽκ ڻ ̼ ȯ øø+鿪׾ ۷ι ӻ 2(̱ ) پ ȣ߼ ӻ ʿ ӻ蹰 뷮꼭񽺸 ȹ̴. ̳ؽ øø ʱ ؿ ӻ ĸſ ӻ蹰 ؿ ִ.

 

ĸ ǥ ̳ؽ CMO ٱ ӻ پ ȣ߼ Ͽ ӻ ʿ ӻ蹰 Ȱϰ ޹ ְ ƴ. øø ߼ ̼ ġ ߵ ֵ ؼ Ƴ ̶ .

 

øø ڼü-2(VEGFR2) ü, Ż ϴ VEGFR2 Ÿ ϴ ִ. ĸ ̱ ȣֿ ƹٽƾ ߼ ȯڸ øø ӻ 2 ϰ ִ. , ȣֿ ߼ ̼ ȯڸ øøʰ PD-1 ü ŰƮ(и Ѹָ) ӻ1b ۷ι MSD(ũ) Բ ϰ ִ.

 

, ĸ 8Ϻ 12ϱ ֵ ִ Ը ̿ о ۷ι ۷ 2020 ̿USA øø Ȳ Ʈߴ. ټ ̿ȸ øø ߰ Ǹ ϰ ִ.

 

# # #

 

()ĸſ

ü ž ̿ ĸ ӻ󰳹 ܰ ߽ ̿ Żȯ̳ ϴ ΰ üġ ߿ ϰ ִ. ׾, 鿪׾, Ȱ ȣ 庴б پ üġ ϰ ִ.

 

ĸ ǥ øø ΰ IgG ȭϴ VEGFR2 ü, ̱ ȣֿ ٽָ ʴ rGBM(߼ ) ȯ 2 ӻ󿬱 ̴. MSD(ũ) rGBM mTNBC(̼ ) øø+Ѹָ ϴ Ib ӻ󿬱 ̴.

 

ĸ HuPhage ̺귯 ý ϰ ִ. ĸ 3G Expression System ȭ ü ϸ, ÷ ǰ ü 񽺸 ϰ ִ. ĸ ƮʻӸ ƴ϶ ٸ ޸ Ȯ Դ


̳ؽ 

̳ؽ ۷ι ȭ ̿Ǿǰ Ź߻ü(CDMO) üǥü, fusion protein, DNA  پ ܹǾǰ GMP  ϰ ̱Ϻ߱  ǰ Ǿǰ ؿ ִ.


    [ ]

    ĸ

    Ȳ 

    042-863-2017

    Soobeen.hwang@pharmabcine.com

    PR

     

    02-6490-7727

    joyful@prbom.com

     

    ȯ 

    02-6490-7732

    khyoo@prbom.com







ĸ, 鿪׾ Ǽ ̾ƼȰ Ź߻ ...
PharmAbcine Present Preclinical Data of Blood Vessel Stabilizing PMC-403 at 2020...